Showing results (351-360 of 365) with videos related to

Sort By:
Pageof 37
Lung Cancer (Amsterdam, Netherlands)|March 12, 2022
Randomized phase 3 study of the anti-disialoganglioside antibody dinutuximab and irinotecan vs irinotecan or topotecan for second-line treatment of small cell lung cancerMartin J Edelman, Mikhail Dvorkin, Konstatin Laktionov, et al.
Journal of the National Cancer Institute|March 19, 2013
Opportunities and challenges in the era of molecularly targeted agents and radiation therapySteven H Lin, Thomas J George, Edgar Ben-Josef, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2009
Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancerLecia V Sequist, Panos M Fidias, Jennifer S Temel, et al.
JCO Precision Oncology|September 7, 2023
Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)Riha Vaidya, Joseph M Unger, Lu Qian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2024
Safety and Tolerability of Letetresgene Autoleucel (GSK3377794): Pilot Studies in Patients with Advanced Non-Small Cell Lung CancerMehmet Altan, Gilberto Lopes, T Jeroen N Hiltermann, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Cancer Discovery|October 29, 2013
mTOR inhibition specifically sensitizes colorectal cancers with KRAS or BRAF mutations to BCL-2/BCL-XL inhibition by suppressing MCL-1Anthony C Faber, Erin M Coffee, Carlotta Costa, et al.
Investigational New Drugs|January 25, 2024
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohortOluwadunni E Emiloju, Jun Yin, Emily Koubek, et al.
Journal for Immunotherapy of Cancer|January 28, 2022
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancerGeorge R Blumenschein, Siddhartha Devarakonda, Melissa Johnson, et al.
AIDS Care|March 22, 2021
The Global Task Force for Chronic Pain in People with HIV (PWH): Developing a research agenda in an emerging fieldJessica S Merlin, M Hamm, F de Abril Cameron, et al.
Pageof 37